Odyssey Health (ODYY) EBITDA Margin (2014 - 2016)

Odyssey Health has reported EBITDA Margin for 3 years, with the latest figure at 207.5% in Q3 2016.

• For the quarter ending Q3 2016, EBITDA Margin changed N/A year-over-year to 207.5%; the trailing twelve-month figure through Apr 2017 stood at 972.18% (down 67667.0% YoY), and the FY2016 full-year result was 196.43%, down 13582.0% from the prior year.
• EBITDA Margin for Q3 2016 stood at 207.5%, down from 13.88% in the prior quarter.
• The five-year high for EBITDA Margin was 13.88% in Q2 2016, with the low at 235.48% in Q2 2015.
• Average EBITDA Margin over 3 years is 106.97%, with a median of 49.03% recorded in 2015.
• Peak annual rise in EBITDA Margin reached 22159 bps in 2016, while the deepest fall reached 22159 bps in 2016.
• Tracing ODYY's EBITDA Margin over 3 years: stood at 28.98% in 2014, then tumbled by 712 bps to 235.48% in 2015, then advanced by 12 bps to 207.5% in 2016.
• The last three EBITDA Margin figures came in at 207.5% (Q3 2016), 13.88% (Q2 2016), and 235.48% (Q2 2015), per Business Quant data.

Peer Comparison